How potatoes can increase the risk of cancer cell

New Post Public Reply Private Reply Replies (2) Message Board
wowhappens28
161
How potatoes can increase the risk of cancer cell growth

http://www.naturalhealth365.com/potatoes-canc...-2325.html

A recent campaign launched by The Food Standards Agency of the UK is warning the public about cancer risks from overcooked potatoes. Potato chips, French fries and well-done roasted potatoes are some of the biggest offenders, but other foods cooked at high temperatures can be problematic as well. Why? Because eating too much of these foods can fuel cancer cell growth due to their acrylamide content.
But, that’s NOT the only health concern. Other foods that pose a risk include packaged crackers, cookies, dry cereals, toasted nuts and peanut butter. Food such as canned black olives, prune juice and roasted cocoa beans also contain acrylamide, as do over-grilled foods that become dark brown or black.
Cancer-causing acrylamide forms due to chemical reaction
The International Agency for Research on Cancer has also flagged these foods due to their acrylamide content. Acrylamide is highest in fried foods, especially fried potatoes. The cancer risk occurs due to “the Maillard reaction” caused by high heat which leads to the formation of harmful acrylamide.
Acrylamide arises in certain carbohydrates, proteins and starchy foods exposed to intense or prolonged heat during processing or cooking. It forms when simple sugars like glucose – exposed to high temperatures – react with the amino acid asparagine.
Studies have established the link between acrylamide and cancer risk in rodents as well as in people during a major review published in Nutrition and Cancer in 2014. The review determined that persons who consumed the highest amounts of acrylamide were more likely to get cancer.
Sweet potato chips pose highest risk for triggering cancer cell growth
While the Maillard reaction is what gives potato chips and fries their taste and crispiness, it can contribute to cancer cell growth. Acrylamide is also present in bread crusts and many foods that are roasted, including nuts. However, sweet potato chips have the most acrylamide at around 4,000 ppm. (Regular potato chips are still high, but contain about half that level.)
While people have been eating these foods for years, the acrylamide compound was located in 2002 when it was determined a chemical reaction takes place when certain carbohydrates, proteins and starchy foods are heated. It was designated a probable carcinogen after research confirmed a correlation with cancer cell growth.
Additional motivation to cut out fried and processed potatoes and other foods
Potato chips and French fries are already on most peoples’ list of foods to avoid or eat only in moderation. Increased awareness about their potential to contribute to cancer cell growth will likely cause even more people to think twice before indulging in these foods.
Other ways to reduce acrylamide consumption include striving not to overcook meats, potatoes and grilled foods at home. While dark browned or blackened foods have an appealing flavor, they come with risks to your health.
Instead, consider steaming, boiling or lightly sautéing foods to minimize acrylamide exposure. In addition, avoid eating heat-processed foods like crackers, packaged cookies, graham crackers and boxed cereals like corn flakes.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Radiofrequency Microneedling: A Fresh Skin Solution?

Updated Category News Views 128

Vet the Process Before Diving In Everyone wants to turn back the clock on their skin, but it's crucial to know what you're getting into. This ain't a quick splash of water on the face; it's radiofrequency microneedling we're talking about. And honey, it’s no fairy tale—it’s science, plain and simple. Drilling Down on Microneedling This procedure, preached by Dr....

Continue Reading
Purina's Docuseries Wins Big at Daytime Emmys

Updated Category News Views 89

Unleashing a Winning Streak Forget stock price fluctuations—Purina Films has struck gold. In a world where brand stories often fall flat or feel contrived, Purina's 'A Different Breed' docuseries just bagged three Daytime Emmy® Awards. It's not every day you see corporate storytelling make a splash like this, but when you blend pets and riveting narratives, magic...

Continue Reading
Flash Tech Sparks New Era in Gas Sensing

Updated Category News Views 38

Revolutionary 10-Millisecond Flash Technique Out of South Korea comes a scientific shake-up that's got eyes on a tiny flash of light poised to change gas sensing technology as we know it. Yep, at Hanyang University ERICA, the boffins have figured out how a quick-fire 10-millisecond zap can turn up the sensitivity dial on gas sensors, especially for the pesky nitrogen...

Continue Reading
KickHouse Partners with Sam Alvey for Glove Line Launch

Updated Category News Views 40

KickHouse Pounces with New Fighter Partnership Looks like KickHouse isn't playing games, folks. They've teamed up with fighter Sam Alvey to launch a new boxing glove line. You got your Warbird, your Desert Ghost, and your Night Ops gloves—names straight out of a war zone. These 16-ounce hammers are out now, and they kickstart a broader gear lineup custom-built for Alvey...

Continue Reading
BioArctic's Moves: Lecanemab Data and Leadership Insights

Updated Category News Views 79

BioArctic's Power Play: A Two-Pronged Update Ever feel like biotechnology is just a series of chess moves? BioArctic's recent maneuvers in the life sciences game certainly hint at that. First, they've got data brewing on lecanemab—this ain't small beans, folks, not with Alzheimer's disease in the crosshairs. Then there's their Nomination Committee. It’s like shaking...

Continue Reading
Ping Identity Tops 2026 Gartner Magic Quadrant: CIAM

Updated Category News Views 20

Turning Heads in the Cybersecurity Space When it comes to digital security, Ping Identity has snagged a top spot in Gartner's 2026 Magic Quadrant for Customer Identity and Access Management (CIAM). Some might gloss over these annual reports like yesterday's news, but Ping isn't just playing around here. They've been tapped as a Leader again, and this accolade highlights...

Continue Reading
Glance's Guide Bridges AI and Human Service Gaps

Updated Category News Views 117

Untangling the AI to Human Transition Ever found yourself stuck in a never-ending loop with AI, screaming for a human voice? You're not alone. According to Glance's 2026 Customer Experience Trends Report, a staggering 76% of consumers are pulling their hair out while repeating themselves when switching service channels. The rub? Only 7% claim they rarely experience this...

Continue Reading
Holiday Shoppers Eye Payment Options Amid Tight Budgets

Updated Category News Views 67

Shoppers Feel the Squeeze As Holidays Approach Hope you brought your umbrella because the holiday season is going to be awash with financial strain and stress for many consumers. According to the latest ETA-TSG Consumer Holiday Spending Study, 44% of consumers are more financially stressed this year compared to last, and the numbers aren't getting any rosier from there....

Continue Reading
Winter Travel Booms: Top Destinations Unveiled for 2026

Updated Category News Views 121

Winter Travel Surge: Rising Demand for Top Destinations Every year as the temperature drops, the excitement for winter travel heats up, and this season's no different. Booking patterns confirm that while people are dreaming of holiday magic, they're also gunning for sun when cold's on the horizon. New York City's holiday glitz leads the domestic charge, backed by a power...

Continue Reading
Orbis International to Boost Global Eye Health Efforts

Updated Category News Views 100

Pledge for Vision In a world where a staggering number of folks wrestle with avoidable vision issues, Orbis International is stepping up to the plate with ambitions that feel as bold as they are necessary. Orbis is pouring a significant $32 million into its mission to beef up eye health systems, train a small army of professionals, and apply AI in eye care. Their big bet...

Continue Reading

Top 5 Most Recently Viewed Articles

Exciting Developments in Titanium Powder Production by PyroGenesis

Updated Category News Views 156

Significant Contract for Titanium Powder Production PyroGenesis Inc., a pioneer in ultra-high temperature processes and a leading technology provider to heavy industry and defense, is making waves in the additive manufacturing sector. The company has announced an initial order for 'fine cut' titanium powder, which has been produced using their advanced NexGen™ plasma...

Continue Reading
Exploring The Impressive Returns of The Hartford Insurance

Updated Category News Views 254

Understanding The Hartford Insurance Group's Growth The Hartford Insurance Group (NYSE: HIG) has displayed impressive market performance over the past five years, outpacing overall market gains significantly. With an annualized return of 26.43%, this company has offered a noteworthy 12.44% lead over the market average. Current market capitalization stands at approximately...

Continue Reading
Exciting New Consumer Product Launches and Trends This Week

Updated Category News Views 520

Highlights of this Week’s Major Consumer Announcements This week brings an exciting selection of consumer and retail news that you won’t want to miss. From the world of fragrances to the latest Halloween trends, here’s a closer look at some captivating announcements that are making waves. Ariana Grande’s Wicked-Inspired Fragrances Ariana Grande has taken things to...

Continue Reading
Occidental Petroleum's Significant Debt Reduction Achievements

Updated Category News Views 274

Occidental Petroleum's Debt Reduction Strategy In a significant stride towards enhancing its financial health, Occidental Petroleum (NYSE: OXY) announced remarkable progress in its debt reduction efforts, achieving a key target of $4.5 billion by the end of 2024. This noteworthy milestone positions the company well as it navigates the complexities of the evolving energy...

Continue Reading
Aptose Unveils Promising New Therapy for AML Patients

Updated Category News Views 218

Aptose Unveils Promising New Therapy for AML Patients In a groundbreaking development, Aptose Biosciences Inc. (NASDAQ: APTO, TSX: APS) recently announced that the initial patients have been dosed in the TUSCANY Phase 1/2 trial. This innovative trial evaluates the effectiveness of tuspetinib (TUS) in combination with venetoclax (VEN) and azacitidine (AZA). This trio...

Continue Reading